Cancer-fighting TKIs can trigger serious heart risks, including hypertension in up to 60% of patients. 🫀 This review outlines vital surveillance strategies to protect patient hearts without interrupting therapy. 🔬✨ Read full paper: tinyurl.com/r7sy6hjh